| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/17/2004 | EP1397357A2 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 03/17/2004 | EP1397356A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 03/17/2004 | EP1397341A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 03/17/2004 | EP1397153A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 03/17/2004 | EP1397150A2 Somatostatin agonists |
| 03/17/2004 | EP1397148A2 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia |
| 03/17/2004 | EP1397142A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 03/17/2004 | EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1397129A1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors |
| 03/17/2004 | EP1397053A1 Oral composition comprising an extract from the bark of albizzia myriophylla |
| 03/17/2004 | EP1259112A4 Nutritional intervention composition for enhancing and extending satiety |
| 03/17/2004 | EP1244434B1 Use of chemotherapeutic agents |
| 03/17/2004 | EP1242364B1 Adamantane derivatives |
| 03/17/2004 | EP1224175B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 03/17/2004 | EP1147102B1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 03/17/2004 | EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/17/2004 | EP1039890B1 Novel salts of metformin and method |
| 03/17/2004 | EP0891332B1 6-phenylpyridyl-2-amine derivatives |
| 03/17/2004 | CN1483043A Chitosan-containing multicomponent composition and process for preparing the same |
| 03/17/2004 | CN1483041A GLP-1 fusion protein |
| 03/17/2004 | CN1483039A Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 03/17/2004 | CN1483034A Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 03/17/2004 | CN1483026A Benzoylpyridazine |
| 03/17/2004 | CN1483024A Vla-4 inhibitors |
| 03/17/2004 | CN1483023A 3-arylindole derivatives and their use as cb2 receptor agonists |
| 03/17/2004 | CN1483022A Crystalline forms of atorvastatin |
| 03/17/2004 | CN1483021A Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 03/17/2004 | CN1482912A Heteroaryl urea neuropeptide yy5 receptor antagonists |
| 03/17/2004 | CN1482906A New clinical treatment |
| 03/17/2004 | CN1482904A Nateglinide-containing hydrophilic pharmaceutical preparation |
| 03/17/2004 | CN1482903A Nateglinide-containing preparation |
| 03/17/2004 | CN1482868A Nutritional composition with health promoting action containing oligosaccharides |
| 03/17/2004 | CN1482231A Ampelopsin healthcare wine |
| 03/17/2004 | CN1482140A Process for extracting medicinal protein from ostrich blood and use thereof |
| 03/17/2004 | CN1482136A Extract of american ginseng fruit saponin, extracting and refining method and medicinal use thereof |
| 03/17/2004 | CN1481888A Pancreas building pills |
| 03/17/2004 | CN1481862A Chinese traditional medicine composition curing viscera inflammation, toxin and endocrine disorder |
| 03/17/2004 | CN1481841A Medication composition for diabetes |
| 03/17/2004 | CN1481831A Phospholipid liposome oral fluid |
| 03/17/2004 | CN1481822A Bee glue tablet for diabetes and preparation process |
| 03/17/2004 | CN1481809A Sodium bialginate for injection and its preparation method |
| 03/17/2004 | CN1481800A Dimaltol vanadium complex tablet formulation for d iabetes and its use |
| 03/17/2004 | CN1481799A Granule, capsule formulation of dimaltol vanadium complex for Diabetes and its use |
| 03/17/2004 | CN1481796A Medication for adiposity |
| 03/17/2004 | CN1481790A Use of composition comprising dihydromyricetin and myricetin in treatment of hyperglycemia |
| 03/17/2004 | CN1142178C Novel peptides and remedy for bone diseases contg. same as active ingredient |
| 03/17/2004 | CN1142153C Benzoylpyridazines |
| 03/17/2004 | CN1141973C Capsule for curing diabetes and its preparation method |
| 03/17/2004 | CN1141970C Compound traditional Chinese medicine tea bag for curing fatty liver and hyperlipemia and its production method |
| 03/17/2004 | CN1141968C Yew health-care composition for reducing blood sugar |
| 03/17/2004 | CN1141943C Production process and product of instant osteocalcium powder composition |
| 03/17/2004 | CN1141934C Health-care oil for regulating blood fat |
| 03/16/2004 | US6706763 Agonistic drug on human peroxisome proliferator-activated receptor (ppar) |
| 03/16/2004 | US6706753 Integrin receptor inhibitors |
| 03/16/2004 | US6706751 Dihydroindole and tetrahydroquinoline derivatives |
| 03/16/2004 | US6706750 Useful in treating obesity and other disorders |
| 03/16/2004 | US6706747 Treating elevated intraocular pressure, depression, non insulin-dependent diabetes, male impotence and obesity which is alleviated by treatment with an alpha 2 blocking agent |
| 03/16/2004 | US6706746 Thiadiazolidin-2,4-dione compound |
| 03/16/2004 | US6706743 β3 adrenergic receptor agonists and uses thereof |
| 03/16/2004 | US6706742 Alpha-amino-acid compounds |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/16/2004 | US6706727 ethyl-4-chloro- or 4-hydroxy- Ascomycin derivatives; pimecrolimus homologues; cultivating Streptomyces hygroscopius to produce the 4-hydroxy derivative; replacement of the hydroxy with chloro under epimerization; antiinflammatory; immunosupression |
| 03/16/2004 | US6706725 Vitamin D analogues |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 03/16/2004 | US6706710 Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 03/16/2004 | US6706709 Treating, for example, proliferative disorders including cancer |
| 03/16/2004 | US6706702 For therapy of neurological and psychological disorders |
| 03/16/2004 | US6706698 Anticholesterol agents |
| 03/16/2004 | US6706695 Antilipemic formulation |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | CA2331446C Biodegradable sustained-release alginate gels |
| 03/11/2004 | WO2004020435A1 Piperidinyl compounds that selectively bind integrins |
| 03/11/2004 | WO2004020421A1 Novel quaternary ammonium compounds |
| 03/11/2004 | WO2004020409A1 Indoles having anti-diabetic activity |
| 03/11/2004 | WO2004020408A1 Indoles having anti-diabetic activity |
| 03/11/2004 | WO2004020407A1 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 03/11/2004 | WO2004020393A1 Dibenzylamine compound and medicinal use thereof |
| 03/11/2004 | WO2004020382A1 Method and device for producing formic acid formates and use of said formates |
| 03/11/2004 | WO2004019983A1 Method of degrading transcriptional factors of saccharometabolism-associated gene, method of inhibiting the degradation and degradation inhibitor |
| 03/11/2004 | WO2004019965A2 Thymus-based tolerogenic approaches for type i diabetes. |
| 03/11/2004 | WO2004019958A1 Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof |
| 03/11/2004 | WO2004019949A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | WO2004019941A1 Glycinamide derivatives as raf-kinase inhibitors |
| 03/11/2004 | WO2004019927A2 Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation |
| 03/11/2004 | WO2004019868A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators |
| 03/11/2004 | WO2003106380A3 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 03/11/2004 | WO2003101923A3 Policosanol compositions, extraction from novel sources, and uses thereof |
| 03/11/2004 | WO2003099759A8 Preparation and application of transhintotalphenolic acid |
| 03/11/2004 | WO2003095607A3 Role of p62 in aging-related disease |
| 03/11/2004 | WO2003092599A3 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 03/11/2004 | WO2003071268A3 Method for discovering pharmacologically active substances |
| 03/11/2004 | WO2003066587A3 Piperidine or pyrrolidine derivatives having an aminoacyl substituted side chain as melancortin-4 receptor agonists |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003059323A3 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 03/11/2004 | WO2003034978A3 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives |
| 03/11/2004 | WO2003033535A3 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 03/11/2004 | WO2003015690B1 Method for treating primary insomnia |